SCHEMBL17215464

SCHEMBL17215464

CCCCO/N=[C]\c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LTA4H P09960 2/20 0.47
▸ TSHR P16473 3/20 0.41
▸ TDP1 Q9NUW8 2/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ CYP1A2 P05177 2/20 0.38
▸ CYP2C9 P11712 2/20 0.38
▸ CYP2C19 P33261 2/20 0.38
▸ ESR1 P03372 2/20 0.38
▸ ALDH1A1 P00352 3/20 0.37
▸ CYP3A4 P08684 2/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ CYP19A1 P11511 1/20 0.37
▸ HPGD P15428 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ MLNR O43193 1/20 0.36
▸ NR1I2 O75469 1/20 0.36
▸ NR3C1 P04150 1/20 0.36
▸ PGR P06401 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17215465 1.00 LTA4H (0.47) LTA4HTSHRTDP1L3MBTL1CYP1A2
SCHEMBL17218512 0.95 LTA4H (0.47) LTA4HTSHRESR1ALDH1A1CYP3A4
SCHEMBL17218515 0.95 LTA4H (0.47) LTA4HTSHRESR1ALDH1A1CYP3A4
SCHEMBL17219802 0.93 LTA4H (0.46) LTA4HTSHRESR1ALDH1A1CYP3A4
SCHEMBL17219801 0.93 LTA4H (0.46) LTA4HTSHRESR1ALDH1A1CYP3A4
SCHEMBL17218223 0.89 LTA4H (0.37) LTA4HTSHRTDP1L3MBTL1ALDH1A1
SCHEMBL17218220 0.89 LTA4H (0.37) LTA4HTSHRTDP1L3MBTL1ALDH1A1
SCHEMBL17986222 0.89 LTA4H (0.37) LTA4HTSHRTDP1L3MBTL1ALDH1A1
SCHEMBL17217078 0.84 DRD2 (0.37) LTA4HESR1ALDH1A1DRD2DRD3
SCHEMBL17217075 0.84 DRD2 (0.37) LTA4HESR1ALDH1A1DRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2940012-B1 TETRAZOLINONE COMPOUND AND APPLICATIONS THEREOF SUMITOMO CHEMICAL CO (JP) 2019-01-30 — — EP disclosed
US-9560850-B2 Tetrazolinone compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-02-07 — — US disclosed
US-20150336908-A1 TETRAZOLINONE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-11-26 — — US disclosed
EP-2940012-A1 TETRAZOLINONE COMPOUND AND APPLICATIONS THEREOF Sumitomo Chemical Company Limited (JP) 2015-11-04 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150336908-A1 TETRAZOLINONE COMPOUND AND USE THEREOF RTN3, CYP51A1, TCOF1 LTA4H 1228/4885TSHR 19/4885TDP1 3489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback